Loading clinical trials...
Loading clinical trials...
Phase 1 Single-Dose Double-Blind Vehicle-Controlled 3-Way Crossover Study Using Thermography to Assess the Pharmacodynamics and Pharmacokinetics of L-Arginine and Sildenafil Contained in Sildenafil Cream 3.6% in Normal Healthy Premenopausal Women
Conditions
Interventions
Sildenafil
Vehicle
+1 more
Locations
1
Canada
Pharma Medica Research, Inc.
Mississauga, Ontario, Canada
Start Date
May 13, 2023
Primary Completion Date
January 26, 2024
Completion Date
October 21, 2024
Last Updated
September 4, 2025
NCT06116045
NCT06651541
NCT04673708
NCT00746967
NCT03592121
NCT03820453
Lead Sponsor
Daré Bioscience, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions